100 related articles for article (PubMed ID: 30699367)
1. Effects of Neddylation and mTOR Inhibition in Acute Myelogenous Leukemia.
Guo N; Azadniv M; Coppage M; Nemer M; Mendler J; Becker M; Liesveld J
Transl Oncol; 2019 Apr; 12(4):602-613. PubMed ID: 30699367
[TBL] [Abstract][Full Text] [Related]
2. Neddylation inhibition sensitises renal medullary carcinoma tumours to platinum chemotherapy.
Shapiro DD; Zacharias NM; Tripathi DN; Karki M; Bertocchio JP; Soeung M; He R; Westerman ME; Gao J; Rao P; Lam TNA; Jonasch E; Perelli L; Cheng EH; Carugo A; Heffernan TP; Walker CL; Genovese G; Tannir NM; Karam JA; Msaouel P
Clin Transl Med; 2023 May; 13(5):e1267. PubMed ID: 37226898
[TBL] [Abstract][Full Text] [Related]
3. Discovery of the 2,4-disubstituted quinazoline derivative as a novel neddylation inhibitor for tumor therapy.
Su J; Li M; Chang Y; Jia M; Zhao M; Guan S; Niu J; Zhang S; Yang H; Sun M
Bioorg Chem; 2024 Apr; 145():107237. PubMed ID: 38442613
[TBL] [Abstract][Full Text] [Related]
4. Targeting neddylation and sumoylation in chemoresistant triple negative breast cancer.
Powell RT; Rinkenbaugh AL; Guo L; Cai S; Shao J; Zhou X; Zhang X; Jeter-Jones S; Fu C; Qi Y; Baameur Hancock F; White JB; Stephan C; Davies PJ; Moulder S; Symmans WF; Chang JT; Piwnica-Worms H
NPJ Breast Cancer; 2024 May; 10(1):37. PubMed ID: 38802426
[TBL] [Abstract][Full Text] [Related]
5. Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity.
Jones TM; Espitia CM; Chipollini J; Lee BR; Wertheim JA; Carew JS; Nawrocki ST
Cancer Res Commun; 2023 Feb; 3(2):245-257. PubMed ID: 36860653
[TBL] [Abstract][Full Text] [Related]
6. Pevonedistat and azacitidine upregulate NOXA (PMAIP1) to increase sensitivity to venetoclax in preclinical models of acute myeloid leukemia.
Cojocari D; Smith BN; Purkal JJ; Arrate MP; Huska JD; Xiao Y; Gorska A; Hogdal LJ; Ramsey HE; Boghaert ER; Phillips DC; Savona MR
Haematologica; 2022 Apr; 107(4):825-835. PubMed ID: 33853293
[TBL] [Abstract][Full Text] [Related]
7. Neddylation-Independent Activities of MLN4924.
Mao H; Sun Y
Adv Exp Med Biol; 2020; 1217():363-372. PubMed ID: 31898238
[TBL] [Abstract][Full Text] [Related]
8. Targeting Protein Neddylation for Cancer Therapy.
Zhou L; Jia L
Adv Exp Med Biol; 2020; 1217():297-315. PubMed ID: 31898235
[TBL] [Abstract][Full Text] [Related]
9. Neddylation: a novel modulator of the tumor microenvironment.
Zhou L; Jiang Y; Luo Q; Li L; Jia L
Mol Cancer; 2019 Apr; 18(1):77. PubMed ID: 30943988
[TBL] [Abstract][Full Text] [Related]
10. Targeting NAE1-mediated protein hyper-NEDDylation halts cholangiocarcinogenesis and impacts on tumor-stroma crosstalk in experimental models.
Olaizola P; Lee-Law PY; Fernandez-Barrena MG; Alvarez L; Cadamuro M; Azkargorta M; O'Rourke CJ; Caballero-Camino FJ; Olaizola I; Macias RIR; Marin JJG; Serrano-Maciá M; Martinez-Chantar ML; Avila MA; Aspichueta P; Calvisi DF; Evert M; Fabris L; Castro RE; Elortza F; Andersen JB; Bujanda L; Rodrigues PM; Perugorria MJ; Banales JM
J Hepatol; 2022 Jul; 77(1):177-190. PubMed ID: 35217064
[TBL] [Abstract][Full Text] [Related]
11. Pevonedistat Suppresses Pancreatic Cancer Growth
Xu J; Li Z; Zhuo Q; Ye Z; Fan G; Gao H; Ji S; Yu X; Xu X; Liu W; Xu W
Front Oncol; 2022; 12():822039. PubMed ID: 35155257
[TBL] [Abstract][Full Text] [Related]
12. Pevonedistat, a NEDD8-Activating Enzyme Inhibitor, Induces Apoptosis and Augments Efficacy of Chemotherapy and Small Molecule Inhibitors in Pre-clinical Models of Diffuse Large B-cell Lymphoma.
Torka P; Mavis C; Kothari S; Belliotti S; Gu J; Sundaram S; Barth M; Hernandez-Ilizaliturri FJ
EJHaem; 2020 Jul; 1(1):122-132. PubMed ID: 33073261
[TBL] [Abstract][Full Text] [Related]
13. Pevonedistat (MLN4924): mechanism of cell death induction and therapeutic potential in colorectal cancer.
Ferris J; Espona-Fiedler M; Hamilton C; Holohan C; Crawford N; McIntyre AJ; Roberts JZ; Wappett M; McDade SS; Longley DB; Coyle V
Cell Death Discov; 2020; 6():61. PubMed ID: 32714568
[TBL] [Abstract][Full Text] [Related]
14. Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer.
McGrail DJ; Garnett J; Yin J; Dai H; Shih DJH; Lam TNA; Li Y; Sun C; Li Y; Schmandt R; Wu JY; Hu L; Liang Y; Peng G; Jonasch E; Menter D; Yates MS; Kopetz S; Lu KH; Broaddus R; Mills GB; Sahni N; Lin SY
Cancer Cell; 2020 Mar; 37(3):371-386.e12. PubMed ID: 32109374
[TBL] [Abstract][Full Text] [Related]
15. The NEDD8-activating enzyme inhibitor MLN4924 sensitizes a TNFR1
El-Mesery M; Rosenthal T; Rauert-Wunderlich H; Schreder M; Stühmer T; Leich E; Schlosser A; Ehrenschwender M; Wajant H; Siegmund D
Cell Death Dis; 2019 Aug; 10(8):611. PubMed ID: 31406107
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of pevonedistat combined with azacitidine, fludarabine, cytarabine in pediatric relapsed/refractory AML: Results from COG ADVL1712.
Tarlock K; Liu X; Minard CG; Isikwei EA; Reid JM; Horton TM; Fox E; Weigel BJ; Cooper T
Pediatr Blood Cancer; 2023 Dec; 70(12):e30672. PubMed ID: 37710306
[TBL] [Abstract][Full Text] [Related]
17. NEDD8-Activating Enzyme Inhibitor MLN4924 Inhibits Both the Tumor Stroma and Angiogenesis in Pancreatic Cancer via Gli1 and REDD1.
Mao W; Zhang L; Rong Y; Kuang T; Wang D; Xu X; Lou W; Li J
Dig Dis Sci; 2023 Apr; 68(4):1351-1363. PubMed ID: 36098876
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of NEDD8 NEDDylation induced apoptosis in acute myeloid leukemia cells via p53 signaling pathway.
Chen Y; Sun L
Biosci Rep; 2022 Aug; 42(8):. PubMed ID: 35880551
[TBL] [Abstract][Full Text] [Related]
19. Acute Myeloid Leukemia-Related Proteins Modified by Ubiquitin and Ubiquitin-like Proteins.
Park SS; Baek KH
Int J Mol Sci; 2022 Jan; 23(1):. PubMed ID: 35008940
[TBL] [Abstract][Full Text] [Related]
20. Drug Repurposing Approach against Novel Coronavirus Disease (COVID-19) through Virtual Screening Targeting SARS-CoV-2 Main Protease.
Chowdhury KH; Chowdhury MR; Mahmud S; Tareq AM; Hanif NB; Banu N; Reza ASMA; Emran TB; Simal-Gandara J
Biology (Basel); 2020 Dec; 10(1):. PubMed ID: 33374717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
